Cipla & Formosa Ink Licensing Deal for Clobetasol Suspension Kumar Jeetendra | March 18, 2025 Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals (6838.TW) for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007). Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain following ocular surgery across 11 countries …
HiMedia Laboratories Honored with the Prestigious Rasayan Udyog Shri Award by the Indian Chemical Society for Excellence in the Chemical and Allied Industry Kumar Jeetendra | February 4, 2025 We are truly honored to share that HiMedia Laboratories Private Limited has been recognized with the prestigious Rasayan Udyog Shri award for our contributions to the Chemical and Allied Industry. This esteemed recognition has been conferred by the Indian Chemical Society (ICS), an institution with a remarkable legacy of 100 years. The award has been …
Indegene Expands Global Delivery Network, Announces A New Center In Hyderabad Kumar Jeetendra | November 18, 2024 Indegene, a digital-first life sciences commercialization company, announced a new center in Hyderabad to strengthen its global delivery operations and better address growing business needs. As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in helping companies accelerate their transformation. This move aligns with Indegene’s …
Alembic honoured with Guinness World Record for Hypertension Awareness Milestone Kumar Jeetendra | November 12, 2024 Alembic Pharmaceuticals Limited, a leading pharmaceutical company, today announced that its Summit division has been recognized by Guinness World Records for collecting the most number of pledges for a hypertension campaign. This recognition underscores the company’s commitment to addressing public health issues in India. Hypertension, or high blood pressure, affects 28.1% of India’s adult population, …
Husky and Kriya Forge Strategic Collaboration with ICHOR Integrated Medical System in India Kumar Jeetendra | September 20, 2024 Husky Technologies™ is excited to announce a major milestone in our collaboration with Kriya Medical Technologies Pvt. Ltd., marked by the successful deployment of the first ICHOR™ integrated medical system in India capable of producing both 13×100 and 13x75mm blood collection tubes. The inauguration ceremony, held on September 18, 2024, at Kriya’s Chennai facility, was …
TM Media Wins Elets Pharma Leadership Award for Leading Biotechnology Company Kumar Jeetendra | September 3, 2024 TM Media is pleased to add the prestigious Elets 6th Pharma Leadership Award for the Leading Biotech Company in the company’s fettle. We would like to mention that the award ceremony took place on August 30th, in Novotel Juhu Mumbai and it was conducted by Elets Technomedia Pvt Lt. Mumbai, India. This award is a …
OmniBRx Biotechnologies and Translational Health Science and Technology Institute (THSTI) Announce Collaboration for Innovations in Cell Therapy Kumar Jeetendra | August 22, 2024 OmniBRx Biotechnologies Pvt Ltd, a pioneer in bioprocess engineering, is thrilled to announce its strategic collaboration with the Translational Health Science and Technology Institute (THSTI), an institute of Biotechnology Research and Innovation Council (BRIC), Department of Biotechnology, Ministry of Science and Technology, Govt of India. The aim of this alliance is to drive the implementation …
Chromcore Lifesciences LLP and Aptar Pharma India Form Strategic Alliance to Enhance Pharmaceutical Development Kumar Jeetendra | May 29, 2024 We are pleased to announce that we have recently entered into a Strategic Alliance with Aptar Pharma to leverage Aptar’s global expertise and bring Chromcore’s end to end product development skillset to Aptar’s vast network of customers. This Alliance aims to build research and development efforts in the South-East Asia and MENA market. As part …
Alembic Pharmaceuticals appoints Mr. Manish Kejriwal as Independent Director Kumar Jeetendra | April 5, 2024 Alembic Pharmaceuticals Limited appoints Mr. Manish Kejriwal as an Independent Director of the company for the period of five consecutive years effective from March 31, 2024. Mr. Kejriwal brings over 30 years of experience in private equity investments and is currently the founder and Managing Partner of Kedaara Capital. Prior to founding Kedaara Capital, Mr. …
Analyzing the Factors Influencing Sun Pharma Share Price Kumar Jeetendra | March 21, 2024 Sun Pharma, a prominent pharmaceutical enterprise in India, has fluctuations in its stock price due to many circumstances. Several factors are known to be significant in determining Sun Pharma’s share price: Financial performance: Sun Pharma’s earnings per share (EPS), profit margin, and revenue are key factors that influence the price of company shares. These figures …
New literature from Copley provides guidance for better inhaler testing Kumar Jeetendra | January 12, 2024 New literature from Copley Scientific, the world’s leading manufacturer and supplier of inhaled product testing equipment, highlights the importance of controlling temperature, relative humidity (RH) and electrostatics in the test environment to maximise the integrity and value of inhaler test data. In an application note and white paper, company experts provide insight into the issues …
BioPulse Solutions marks its inaugural year with a ₹360 million valuation Kumar Jeetendra | January 11, 2024 BioPulse Solutions Pvt Ltd., proudly announces significant milestones and achievements at the start of 2024 as it continues to bring in innovations in bioprocessing technologies that would significantly benefit the biopharma industry. BioPulse Solutions set out with the initial goals of introducing innovative solutions in Single-Use Bioprocessing Technology, redefining customization for the industry. Having inaugurated …
